Back to Trades
Hamill John P.
SrVP/CFO/Prin Fin & Acct OfcrCIK 0001716213
Profile
- Filings
- 3
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Hamill John P., SrVP/CFO/Prin Fin & Acct Ofcr, accounts for 3 disclosed filings worth $61.5K, all concentrated in Aprea Therapeutics, Inc. (APRE), active 2026. The record is heavily weighted toward buying, with $5.1K in purchases against $0 in sales. The largest single open-market purchase on record is $5.1K in Aprea Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Apr 1 | APRE Aprea Therapeutics, Inc. | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Other | $21.2K |
| Mar 16 | APRE Aprea Therapeutics, Inc. | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Grant | $30.9K |
| Feb 2 | APRE Aprea Therapeutics, Inc. | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Buy | $5.1K |
3 filings